A new study has found evidence linking the use of GLP-1 medications like Ozempic and Wegovy to lower death rates in colon cancer patients. The University of California, San Diego study examined data ...

At long last, a bit of bright news emerges from the bleak subject of early-onset colorectal cancer. A recent report published ...

Patients with colon cancer using GLP-1 receptor agonists (the class of drugs behind treatments like Ozempic, Wegovy, and Mounjaro) had substantially lower five-year death rates than those not using ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

The American Cancer Society updated colorectal cancer screening guidelines, adding blood-based tests and reaffirming screening should begin at age 45.

GLP-1 receptor agonists like Ozempic and Wegovy may increase survival among patients with colon cancer, reported a new study published in Cancer Investigation. GLP-1 receptor agonists were originally ...

NORFOLK, Va. — A new report from the American Cancer Society is raising concern among health professionals about a cancer increasingly affecting younger Americans. Researchers say colorectal cancer is ...

For some Duke colleagues, cancer arrived during years spent building careers, raising families or planning for the future.

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. A three-year exercise program improved ...

Cases of bowel cancer - also known as colorectal cancer - have surged among younger adults in recent years, with one in 10 ...